|
Company
Roster
|
Total
Insiders : |
56 |
|
|
Total
Direct Shares :
|
17,442,230 |
|
Total
Indirect Shares :
|
5,520,254 |
|
%
Held by Insiders:
|
32.55% |
|
|
|
Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Zoon Kathryn C |
Director |
2023-06-02 |
49,971 |
2016-11-08 |
0 |
Zink Thomas |
SVP & CMO |
2007-05-18 |
990 |
2007-05-18 |
0 |
Williams Paul Anthony |
SVP, Products Business |
2024-03-01 |
24,882 |
|
0 |
White Marvin L |
Director |
2023-05-25 |
50,949 |
2010-06-04 |
0 |
Sullivan Louis |
Director |
2023-05-25 |
87,265 |
2010-05-20 |
0 |
Strei Katherine |
EVP, Chief HR Officer |
2023-02-28 |
62,824 |
|
0 |
Smith Karen L. |
EVP, Chief Medical Officer |
2021-05-07 |
11,888 |
2021-02-24 |
0 |
Saran Atul |
EVP, Chief Strat & Dev Officer |
2023-02-28 |
86,645 |
2017-08-08 |
0 |
Richard Ronald |
Director |
2023-05-25 |
53,684 |
2008-05-05 |
0 |
Niederhuber John |
Director |
2016-05-18 |
30,300 |
2010-08-23 |
0 |
Myers Robert Calvin |
10% Owner |
|
0 |
2006-11-14 |
1,934,849 |
Mulligan Seamus |
Director |
2019-03-19 |
48,572 |
2019-03-19 |
545,590 |
Microscience Investments Ltd |
Member of 13(d) group, 10% Owner |
2007-03-08 |
0 |
|
0 |
Michigan Biologic Products, Inc. |
Member 13(d) group owning >10% |
2008-03-28 |
1,269,390 |
|
0 |
Merlin General Partner Ii Ltd (as Managing Partner |
|
2007-03-08 |
29,972 |
|
0 |
Merlin General Partner Ii Ltd (as General Partner |
|
2007-03-08 |
498,722 |
|
0 |
Lockhart Stephen |
SVP Product Development |
2010-11-11 |
6,980 |
2008-11-26 |
0 |
Lindahl Richard S |
EVP, Chief Financial Officer |
2024-03-01 |
158,742 |
2018-05-08 |
0 |
Labinger Barry |
EVP, Biosciences Div. |
2015-11-13 |
25,182 |
2013-11-12 |
0 |
Kramer Robert |
President and CEO, Director |
2023-06-09 |
506,059 |
2018-05-08 |
1,000 |
Kirk Sean |
EVP, Manufacturing & Tech Ops |
2021-03-31 |
17,776 |
2020-02-25 |
0 |
Keese Kyle |
EVP, BioSciences Division |
2011-03-15 |
18,759 |
2007-05-29 |
0 |
Katkin Keith |
Director |
2023-05-25 |
42,442 |
2022-04-02 |
0 |
Joulwan George A |
Director |
2022-05-26 |
40,244 |
2013-07-17 |
0 |
Intervac, L.l.c. |
10% Owner |
2012-09-18 |
4,344,250 |
|
0 |
Intervac Management, L.l.c. |
|
2006-11-14 |
719,275 |
|
0 |
Havey Adam |
EVP, Business Operations |
2023-06-09 |
174,398 |
2011-03-08 |
0 |
Hauer Jerome M |
Director |
2023-05-25 |
57,508 |
2010-03-09 |
0 |
Hartzel William |
SVP, Bioservices |
2024-04-07 |
34,274 |
|
0 |
Harsanyi Zsolt |
Chairman, Director |
2023-05-25 |
71,899 |
2009-06-10 |
0 |
Glessner Coleen |
EVP, Quality & Ethics, and CPL |
2024-04-07 |
164,383 |
2022-04-08 |
0 |
Gibellini Mauro |
SVP, Corporate Dev. |
2007-06-04 |
0 |
2007-04-01 |
1,375,084 |
Fox Jennifer Lynne |
EVP, Ext Aff, GC, Corp Sec |
2024-03-01 |
173,758 |
2022-03-01 |
0 |
Fowler Neal Franklin |
Director |
2023-10-03 |
118,670 |
2023-10-03 |
0 |
Esposito Denise |
CLO |
2008-12-12 |
500 |
|
0 |
Emergent Biosolutions Inc. |
|
2019-05-23 |
13,604 |
|
0 |
Elsey R Don |
Chief Financial Officer |
2012-03-14 |
26,614 |
2006-11-20 |
0 |
El-Hibri Fuad |
Director |
2021-12-03 |
1,136,971 |
2021-12-03 |
206,434 |
Degolyer Donald W |
Director |
2023-10-03 |
118,670 |
2023-10-03 |
0 |
Dayal Sujata Tyagi |
Director |
2023-05-25 |
45,699 |
2022-07-21 |
0 |
Chatfield Steven |
EVP, BioSciences |
2013-03-14 |
28,000 |
2007-02-23 |
0 |
Biovac, L.l.c. |
|
2006-11-14 |
1,599,155 |
|
0 |
Biopharm, L.l.c. |
10% Owner |
2010-05-27 |
2,265,043 |
|
0 |
Biologika, L.l.c. |
Member 13(d) group owning >10% |
2008-06-04 |
1,399,764 |
|
0 |
Bailey Sue |
Director |
2021-03-04 |
24,427 |
2009-03-11 |
0 |
Arpi, L.l.c. |
|
2006-11-14 |
658,254 |
|
0 |
Arcuri Edward |
COO |
2007-05-08 |
76,722 |
2007-05-08 |
0 |
Apax Europe IV Gp Co Ltd |
|
|
0 |
2007-03-08 |
1,455,361 |
Advent Private Equity Fund III Gmbh & Co Kg |
|
2007-03-08 |
18,118 |
|
0 |
Advent Private Equity Fund Iii Affiliates |
|
2007-03-08 |
15,098 |
|
0 |
Advent Private Equity Fund Iii A Ltd Partnership |
|
2007-03-08 |
468,355 |
|
0 |
Advent Private Equity Fund Iii D Ltd Partnership |
|
2007-03-08 |
125,921 |
|
0 |
Advent Private Equity Fund Iii C Ltd Partnership |
|
2007-03-08 |
64,018 |
|
0 |
Advent Private Equity Fund Iii B Ltd Partnership |
|
2007-03-08 |
229,497 |
|
0 |
Advent Management Iii L P |
|
2007-03-08 |
4,530 |
|
0 |
Abdun-Nabi Daniel |
CEO, Director |
2019-03-04 |
142,617 |
2019-03-04 |
1,936 |
|